We're back now with Alumis for a fireside chat. We have CEO, Martin Babler; and CFO, John Schroer for a fireside. Maybe I'll start off by sending it back to Martin for a quick company overview, and ...

This site contains REAL public records data including criminal records, background reports, photos, court documents, address information, phone numbers, civil judgments, properties owned, social media ...

This site contains REAL public records data including criminal records, background reports, photos, court documents, address information, phone numbers, civil judgments, properties owned, social media ...

Alumis Inc. (NASDAQ:ALMS) is one of the 11 Best New Penny Stocks to Buy Right Now. On May 21, Alumis Inc. (NASDAQ:ALMS) reported that it has completed its merger with ACELYRIN, Inc. As part of this ...

On Monday, Morgan Stanley resumed its coverage of Alumis Inc. (NASDAQ:ALMS) with an Overweight rating and a $23 price target after the company’s recent merger with Acelyrin and its Q1 2025 earnings ...

In March, the couple announced they're expecting their first child together Stefanie Keenan/Getty Images Christian McCaffrey is revealing his wife Olivia Culpo's surprising pregnancy craving as they ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Hamilton County will issue a ...

Alumis, Inc. (NASDAQ:ALMS) stock is trading higher on Tuesday after the company announced it entered into a collaboration and licensing agreement with Kaken Pharmaceuticals. What To Know: Under the ...

Shares of Alumis (NASDAQ:ALMS) traded ~14% higher in the premarket on Tuesday after the California-based biopharma announced a collaboration and licensing agreement with Japanese drugmaker Kaken ...

The Department of Government Efficiency is the new Trump administration’s main vehicle for at least starting the process of change at many federal agencies and on a very fast turn. Natalie Alms, who ...

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Alumis Inc. (NASDAQ: ALMS) and ACELYRIN, INC. is fair to Alumis shareholders. Upon ...